<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES ACT OF 1934
DATE OF REPORT: DECEMBER 23, 1998
COLORADO MEDTECH, INC.
----------------------------------------
(Exact name of registrant as specified in its charter)
COLORADO 000-12471 84-0731006
- ---------------------------- ---------------- --------------
(State or other jurisdiction (Commission File I.R.S. Employer
of incorporation) Number) Identification No.)
6175 LONGBOW DRIVE
BOULDER, COLORADO 80301
---------------------------------
(Address, including zip code, of principal executive offices)
(303) 530-2660
-------------------
(Registrant's telephone number,
including area code)
<PAGE>
ITEM 5. OTHER EVENTS.
On December 23, 1998, Colorado MEDtech, Inc. (the "Company")
adopted a Shareholder Rights Plan. The Rights Plan is similar to plans
adopted by many public companies.
In connection with the adoption of the Rights Plan, the Board declared a
dividend of one Preferred Stock Purchase Right for each outstanding share of
the Company's Common Stock. Each Right, which is not presently exercisable,
entitles the holder to purchase one one-hundredth of a share of Preferred
Stock (the "Preferred Stock") at an exercise price of $55.00. In the event
that any person acquires 15% or more of the outstanding shares of the
Company's Common Stock, each holder of a Right (other than the acquiring
person or group) will be entitled to receive, upon payment of the exercise
price, that number of shares of Common Stock having a market value equal
to two times the exercise price.
The distribution of the Rights will be made to shareholders of record on
December 23, 1998. The Rights will expire on December 23, 2008. The Rights
distribution is not taxable to shareholders. Details of the Rights
distribution are contained in a "Summary of Rights to Purchase Preferred
Shares", which will be mailed to all shareholders of the Company.
-2-
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DATED, this 7th day of January, 1999.
COLORADO MEDTECH, INC.
By: /s/ John V. Atanasoff, II
----------------------------
John V. Atanasoff, II
Chief Executive Officer
-3-